FDA's drug review process and the package label: strategies for writing successful FDA submissions

This title provides guidance to pharmaceutical companies for writing FDA-submissions, such as the NDA, BLA, clinical study reports, and investigator's brochures.

The author provides guidance to medical writers for drafting FDA-submissions in a way more likely to persuade FDA reviewers to grant approval of the drug.